B-B4-DM1 selectively reduced growth and survival of different CD138+ MM cell lines and in in vivo mouse models mediated promotion of MM regression, improvement in OS and reduction in the level of circulating human M protein at well tolerated doses (164). Here, SDC1 is linked to Miyoshi myopathy.